AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 165029
Drug: tibric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibric acid 1,250 mg
Trial: 165029
Drug: tibric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibric acid 500 mg
Trial: 165029
Drug: tibric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibric acid 750 mg
Trial: 165029
Drug: tibric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibric acid (all doses)
Trial: 31612281
Drug: Vaginal Er:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal Er:YAG laser therapy
Trial: 28723333
Drug: Enhanced antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced antimicrobial prophylaxis (continuous trimethoprim-sulfamethoxazole, at least 12 weeks of isoniazid-pyridoxine, 12 weeks of fluconazole, 5 days of azithromycin, single dose of albendazole)
Trial: 24219768
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU; n=42)
Trial: 19626559
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine (EBM) interventions in brain injury rehabilitation
Trial: 8395315
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg in the morning and at bedtime
Trial: 8395315
Drug: Antibacterial drugs
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibacterial drugs (gentamicin, terramycin, furazolidone, berberine)
Trial: 2439568
Drug: ARA-AMP 10
RxNorm normalized name: 2-fluoro ARA-A
DrugBank: Fludarabine (DB01073)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARA-AMP 10 mg/kg/day for 5 days followed by 5 mg/kg/day for 23 days (15 patients)
Trial: 2439568
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (14 patients)
Trial: 28254962
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine (up to 2 mg/kg)
Trial: 28254962
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol (up to 2.5 mg/kg)
Trial: 25617503
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 20 mg/kg/day
Trial: 23758305
Drug: Ultrasound-guided three-in-one
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided three-in-one femoral nerve block plus morphine (FNB group)
Trial: 23758305
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (placebo plus morphine) (SC group)
Trial: 18928094
Drug: Danhong Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danhong Injection (DHI) 1.5 mL/kg
Trial: 19848198
Drug: Danhong Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danhong Injection (DHI)
Trial: 16382131
Drug: Tdap vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap vaccine (single dose)
Trial: 16382131
Drug: Tdap and
RxNorm normalized name: metformin and ertugliflozin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap and MCV4 vaccines
Trial: 11980744
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg pethidine and 25 mg promethazine (premedication group)
Trial: 213837
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amitriptyline and DHE
Trial: 30845038
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: single dose of 2.0 g of TXA orally at 2 hours preoperatively
Trial: 30845038
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3 hours postoperatively
Trial: 30845038
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3 and 9 hours postoperatively
Trial: 30845038
Drug: Group D:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group D: 2.0 g of TXA orally at 2 hours preoperatively + 1.0 g at 3, 9, and 15 hours postoperatively
Trial: 29924009
Drug: IMRT +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMRT + chemotherapy
Trial: 27858874
Drug: Placebo rTMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo rTMS treatments
Trial: 24854296
Drug: 2MD (2‐methylene‐19‐nor‐(20S)‐1α,25‐dihydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2MD (2‐methylene‐19‐nor‐(20S)‐1α,25‐dihydroxyvitamin D3) after 3 daily oral doses for 4 weeks in postmenopausal women
Trial: 17427529
Drug: Overall antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall antibiotics
Trial: 8527277
Drug: Teicoplanin infusion
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin infusion at a dose of 6 mg kg‐1 for 30 min
Trial: 8047827
Drug: Omeprazole, 40
RxNorm normalized name: Omeprazole, 40 mg oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, 40 mg once daily
Trial: 2093020
Drug: Ranitidine, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 300 mg b.i.d.
Trial: 2093020
Drug: Omeprazole, 20
RxNorm normalized name: Omeprazole, 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, 20 mg o.m.
Trial: 361056
Drug: Doxapram hydrochloride
RxNorm normalized name: Doxapram Hydrochloride
DrugBank: Doxapram (DB00561)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxapram hydrochloride (80 mg for females, 95 mg for males)
Trial: 27468823
Drug: 7.0 mg
RxNorm normalized name: NITENPYRAM 57.0 mg ORAL TABLET [CAPSTAR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.0 mg betamethasone
Trial: 19780002
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg lornoxicam
Trial: 26521817
Drug: Standard H
RxNorm normalized name: ALCOHOL 48 mL in 60 mL TOPICAL LIQUID [Silver Standard Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard H pylori triple therapy (clarithromycin, metronidazole and lansoprazole)
Trial: 26521817
Drug: Standard otitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard otitis media with effusion therapy (amoxicillin and clavulanate)
Trial: 26521817
Drug: Amoxicillin and
RxNorm normalized name: omeprazole, amoxicillin and rifabutin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin and clavulanate (for H pylori stool antigen negative children)
Trial: 19638648
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to colposcopy with immediate treatment based on colposcopic appearance
Trial: 17289479
Drug: Esmolol, 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol, 1.5 mg/kg IV
Trial: 17289479
Drug: Nicardipine, 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine, 0.03 mg/kg IV
Trial: 9925067
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg nebulized albuterol
Trial: 9925067
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg nebulized albuterol
Trial: 6604469
Drug: 0.125 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg/kg diazepam
Trial: 6604469
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg diazepam
Trial: 6604469
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg diazepam
Trial: 30633170
Drug: 0.6 mg·kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg·kg rocuronium
Trial: 30633170
Drug: 0.2 mg·kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg·kg cisatracurium
Trial: 26898856
Drug: Feedback intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Feedback intervention (letter from Chief Medical Officer and leaflet on antibiotics)
Trial: 26898856
Drug: Patient-focused intervention
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-focused intervention (patient-focused information promoting reduced use of antibiotics)
Trial: 18656083
Drug: PureVision lenses
RxNorm normalized name: Precise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PureVision lenses with biguanide-preserved solutions (ReNu MultiPlus, Complete MoisturePlus, AQuify)
Trial: 15320472
Drug: Nicorandil infusion
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil infusion during coronary reperfusion therapy
Trial: 15320472
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment with Nicorandil
Trial: 3101154
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume increased (1 L to 1.5 L and 2 L)
Trial: 26264387
Drug: Fortified milk
RxNorm normalized name: Fortified milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified milk (1000 mg calcium for pre-M women and 1200 mg calcium for PM women, 96 mg magnesium, 2.4 mg zinc, 15 µg vitamin D, 4 g FOS-inulin per day)
Trial: 26264387
Drug: Regular milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular milk (500 mg calcium per day)
Trial: 20360607
Drug: Physical therapy-supervised
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy-supervised rehabilitation program (17 physical therapy sessions)
Trial: 1682593
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (40 ppm in air)
Trial: 1682593
Drug: Prostacyclin (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostacyclin (24 micrograms/h, intravenous infusion)
Trial: 6759061
Drug: mianserin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mianserin (30 to 60 mg daily)
Trial: 6759061
Drug: nortriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nortriptyline (75 to 150 mg daily)
Trial: 29847892
Drug: Irsogladine maleate
RxNorm normalized name: maleate
DrugBank: Irsogladine (DB13056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irsogladine maleate 2 mg, twice daily (39 patients)
Trial: 21249385
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (Cr) 2 × 5 g/day for 3 weeks
Trial: 17033039
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m2
Trial: 14739039
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 and 100 mg/m2 combined)
Trial: 17033039
Drug: Docetaxel (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (all doses)
Trial: 11596697
Drug: Three-day regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-day regimen (group A): lansoprazole 30 mg p.o. twice daily on day 1, followed by lansoprazole 30 mg p.o. twice daily, amoxicillin 1 g p.o. twice daily, and azithromycin 500 mg p.o. twice daily on days 2 and 3.
Trial: 11596697
Drug: Five-day regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five-day regimen (group B): lansoprazole 30 mg p.o. twice daily, amoxicillin 1 g p.o. twice daily for two additional days after the three-day regimen.
Trial: 9723660
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray 200 microg once daily
Trial: 9723660
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray 400 microg twice daily
Trial: 9723660
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone 7.5 mg once daily
Trial: 9723660
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone 15 mg once daily
Trial: 8045490
Drug: Adjuvant bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant bolus infusion of Lipiodol containing doxorubicin and mitomycin C
Trial: 23467365
Drug: Zolpidem (Ambien),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (Ambien), a short‐acting GABAA agonist hypnotic
Trial: 16075290
Drug: Nicotine cigarettes
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine cigarettes (Quest 1, yield of 0.6 mg) with accurate dose instructions
Trial: 16075290
Drug: Nicotine cigarettes
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine cigarettes (Quest 1, yield of 0.6 mg) with no dose instructions
Trial: 16075290
Drug: Denicotinized cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denicotinized cigarettes (Quest 3, yield of 0.05 mg) with accurate dose instructions
Trial: 16075290
Drug: Denicotinized cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denicotinized cigarettes (Quest 3, yield of 0.05 mg) with no dose instructions
Trial: 12525510
Drug: Paclitaxel (3-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (3-hour infusion at 175 mg/m2)
Trial: 12525510
Drug: Flat-fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flat-fixed dose of paclitaxel (300 mg)
Trial: 10811496
Drug: Docetaxel (85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (85 mg/m2) and Cisplatin (75 mg/m2) q3w for up to eight cycles
Trial: 15163169
Drug: Docetaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (100 mg/m2)
Trial: 8785111
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment at 50 mJ, 10 pps for 3 minutes
Trial: 8785111
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment at 80 mJ, 10 pps for 3 minutes
Trial: 2070108
Drug: Streptokinase (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase (1.5 million units intravenous)
Trial: 2070108
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no fibrinolytic treatment)
Trial: 7391250
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose alcohol (Incentive Gain)
Trial: 7391250
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose alcohol (Incentive Loss)
Trial: 7391250
Drug: No-dose alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No-dose alcohol
Trial: 23647811
Drug: n-3 PUFAs
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFAs infusion
Trial: 23647811
Drug: n-3 PUFAs
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFAs infusion and Control
Trial: 14766335
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 to 80 mg/day
Trial: 11348605
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 to 40 mg/day
Trial: 11255134
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Resistance Training and Walking (RT/W)
Trial: 8025759
Drug: ONO-1078 (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-1078 (225 mg)
Trial: 2527051
Drug: Acitretin (0.34-0.44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (0.34-0.44 mg/kg body weight) + UVB phototherapy (ReUVB)
Trial: 979832
Drug: Delta9-tetrahydrocannabinol (THC)
RxNorm normalized name: delta9-tetrahydrocannabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delta9-tetrahydrocannabinol (THC) 10 mg/70 kg
Trial: 979832
Drug: Ethanol 0-5
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0-5 g/kg
Trial: 979832
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of THC and ethanol
Trial: 25296725
Drug: LY2603618 (275
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2603618 (275 mg i.v. infusion) with desipramine (50 mg oral)
Trial: 25296725
Drug: Desipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine (50 mg oral) alone
Trial: 19194313
Drug: Lopinavir/ritonavir film-coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir film-coated tablet formulation (LPV/r-fct)
Trial: 19194313
Drug: Lopinavir/ritonavir soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir soft gelatine capsules (LPV/r-sgc)
Trial: 15386822
Drug: Oralin spray
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oralin spray (100 u)
Trial: 15386822
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection (0.1 u/kg)
Trial: 11293553
Drug: Cefprozil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefprozil (30 mg/kg/d in 2 divided doses)
Trial: 11293553
Drug: Amoxicillin/clavulanate (45/6.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (45/6.4 mg/kg/d plus amoxicillin 45 mg/kg/d in 2 divided doses)
Trial: 9555662
Drug: G-699->C polymorphism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-699->C polymorphism in the putative promoter region
Trial: 9555662
Drug: A1098->G polymorphism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A1098->G polymorphism in exon 3
Trial: 8035028
Drug: Granulocyte-macrophage colony-stimulating
RxNorm normalized name: Granulocyte macrophage-colony stimulating factor
DrugBank: Molgramostim (DB12525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF), 5 micrograms/kg daily for 10 days
Trial: 11382894
Drug: GHRH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH treatment
Trial: 26239632
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (OM) therapeutic dose (40 mg)
Trial: 26239632
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (OM) supratherapeutic dose (160 mg)
Trial: 26239632
Drug: Moxifloxacin (MOXI;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (MOXI; 400 mg)
Trial: 24041330
Drug: Cochlear implant
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implant users (CI)
Trial: 19827656
Drug: Anti-platelet treatment
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-platelet treatment
Trial: 16160603
Drug: Folic acid,
RxNorm normalized name: folic acid, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folic acid, 10 mg/d for 7 days
Trial: 11872674
Drug: Intravenous propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propranolol (IV PROP, 80 microg/min)
Trial: 11872674
Drug: Intravenous phentolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous phentolamine (IV PHEN, 500 microg/min)
Trial: 11872674
Drug: Intra-arterial phentolamine
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial phentolamine (IA PHEN, 12 microg/min per 100 ml forearm tissue)
Trial: 9539464
Drug: Modified preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified preparation form
Trial: 9539464
Drug: Conventional preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional preparation form
Trial: 1098132
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of glucose and insulin
Trial: 1098132
Drug: Glucose infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusions without insulin
Trial: 18083781
Drug: COX2 inhibition
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: COX2 inhibition using 200 mg celecoxib once daily for 14 days
Trial: 11197785
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (NTG‐TTS)
Trial: 9148337
Drug: Benznidazole (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benznidazole (5 mg/kg/day for 30 days)